Clinical trial
Investigation of the Effect of Erector Spinae Plane Block on Systemic Immuno-Inflammatory Index in Breast Cancer Surgery: A Prospective Randomized Controlled Study
NCT06954324 is registered in ClinicalTrials.gov with Namik Kemal University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of the Effect of Erector Spinae Plane Block on Systemic Immuno-Inflammatory Index in Breast Cancer Surgery: A Prospective Randomized Controlled Study
- Lead sponsor
- Namik Kemal University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 15, 2021
- Completion date
- February 1, 2023
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, erector spinae plane block, systemic immune-inflammatory index